232 related articles for article (PubMed ID: 33558447)
1. Combined identification of
Zhao Y; Yang B; Chen D; Zhou X; Wang M; Jiang J; Wei L; Chen Z
Aging (Albany NY); 2021 Feb; 13(3):4696-4712. PubMed ID: 33558447
[TBL] [Abstract][Full Text] [Related]
2. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
Tang Y; Zhang Y; Hu X
Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
[TBL] [Abstract][Full Text] [Related]
3. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
[TBL] [Abstract][Full Text] [Related]
4. A novel lncRNA, TCONS_00006195, represses hepatocellular carcinoma progression by inhibiting enzymatic activity of ENO1.
Yu S; Li N; Huang Z; Chen R; Yi P; Kang R; Tang D; Hu X; Fan X
Cell Death Dis; 2018 Dec; 9(12):1184. PubMed ID: 30518748
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence.
Yan P; Huang Z; Mou T; Luo Y; Liu Y; Zhou B; Cao Z; Wu Z
BMC Cancer; 2021 Apr; 21(1):436. PubMed ID: 33879119
[TBL] [Abstract][Full Text] [Related]
6. ARID1A deficiency promotes progression and potentiates therapeutic antitumour immunity in hepatitis B virus-related hepatocellular carcinoma.
Xing T; Li L; Rao X; Zhao J; Chen Y; Ju G; Xu Y; Gao X; Dong G; Xia X; Guan Y; Zhang L; Wen Z; Liang J
BMC Gastroenterol; 2024 Jan; 24(1):11. PubMed ID: 38166741
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma.
He F; Li J; Xu J; Zhang S; Xu Y; Zhao W; Yin Z; Wang X
J Exp Clin Cancer Res; 2015 May; 34(1):47. PubMed ID: 25975202
[TBL] [Abstract][Full Text] [Related]
8. Identification of an autophagy-related gene signature that can improve prognosis of hepatocellular carcinoma patients.
Huo X; Qi J; Huang K; Bu S; Yao W; Chen Y; Nie J
BMC Cancer; 2020 Aug; 20(1):771. PubMed ID: 32807131
[TBL] [Abstract][Full Text] [Related]
9. Genome-Wide Association Study of MKI67 Expression and its Clinical Implications in HBV-Related Hepatocellular Carcinoma in Southern China.
Yang CK; Yu TD; Han CY; Qin W; Liao XW; Yu L; Liu XG; Zhu GZ; Su H; Lu SC; Chen ZW; Liu Z; Huang KT; Liu ZT; Liang Y; Huang JL; Mo ZN; Qin X; Li L; Xiao KY; Peng MH; Winkle CA; O'Brien SJ; Peng T
Cell Physiol Biochem; 2017; 42(4):1342-1357. PubMed ID: 28700999
[TBL] [Abstract][Full Text] [Related]
10. Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma.
Zhu S; Huang X; Zhang K; Tan W; Lin Z; He Q; Chen Y; Shang C
Cancer Med; 2019 Dec; 8(18):7679-7692. PubMed ID: 31674731
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
[TBL] [Abstract][Full Text] [Related]
12. The AP2M1 gene expression is a promising biomarker for predicting survival of patients with hepatocellular carcinoma.
Cho SH; Pak K; Jeong DC; Han ME; Oh SO; Kim YH
J Cell Biochem; 2019 Mar; 120(3):4140-4146. PubMed ID: 30260026
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of genomic and immunological profiles in Chinese and Western hepatocellular carcinoma populations.
Li W; Wu H; Xu X; Zhang Y
Aging (Albany NY); 2021 Apr; 13(8):11564-11594. PubMed ID: 33867349
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic value of WNT family gene expression in hepatitis B virus‑related hepatocellular carcinoma.
Han Q; Wang X; Liao X; Han C; Yu T; Yang C; Li G; Han B; Huang K; Zhu G; Liu Z; Zhou X; Su H; Shang L; Gong Y; Song X; Peng T; Ye X
Oncol Rep; 2019 Sep; 42(3):895-910. PubMed ID: 31322232
[TBL] [Abstract][Full Text] [Related]
15. Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma.
Huang XT; Chen LH; Huang CS; Li JH; Cai JP; Chen W; Yin XY
Dig Surg; 2019; 36(5):426-432. PubMed ID: 30481744
[TBL] [Abstract][Full Text] [Related]
16. Co-expression of LASS2 and TGF-β1 predicts poor prognosis in hepatocellular carcinoma.
Ruan H; Wang T; Yang C; Jin G; Gu D; Deng X; Wang C; Qin W; Jin H
Sci Rep; 2016 Sep; 6():32421. PubMed ID: 27581744
[TBL] [Abstract][Full Text] [Related]
17. Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis.
Miao R; Luo H; Zhou H; Li G; Bu D; Yang X; Zhao X; Zhang H; Liu S; Zhong Y; Zou Z; Zhao Y; Yu K; He L; Sang X; Zhong S; Huang J; Wu Y; Miksad RA; Robson SC; Jiang C; Zhao Y; Zhao H
J Hepatol; 2014 Oct; 61(4):840-9. PubMed ID: 24859455
[TBL] [Abstract][Full Text] [Related]
18. Multiple novel hepatocellular carcinoma signature genes are commonly controlled by the master pluripotency factor OCT4.
Ye C; Zhang X; Chen X; Cao Q; Zhang X; Zhou Y; Li W; Hong L; Xie H; Liu X; Cao H; Wang YJ; Kang B
Cell Oncol (Dordr); 2020 Apr; 43(2):279-295. PubMed ID: 31848930
[TBL] [Abstract][Full Text] [Related]
19. Knowledge-based analyses reveal new candidate genes associated with risk of hepatitis B virus related hepatocellular carcinoma.
Jiang D; Deng J; Dong C; Ma X; Xiao Q; Zhou B; Yang C; Wei L; Conran C; Zheng SL; Ng IO; Yu L; Xu J; Sham PC; Qi X; Hou J; Ji Y; Cao G; Li M
BMC Cancer; 2020 May; 20(1):403. PubMed ID: 32393195
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value and oncogene function of heterogeneous nuclear ribonucleoprotein A1 overexpression in HBV-related hepatocellular carcinoma.
Ke RS; Zhang K; Lv LZ; Dong YP; Pan F; Yang F; Cai QC; Jiang Y
Int J Biol Macromol; 2019 May; 129():140-151. PubMed ID: 30731163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]